The first joint study to be conducted across all twelve clinical trial units at the German Center for Infection Research (DZIF) has been initiated. The aim of the study is to improve vaccine
An artificially produced inhibitor curbs Ebola virus replication and could be used to develop drugs for life-threatening Ebola virus epidemics. An European team of scientists bases this hope on
The National Reference Center at the Research Center Borstel has confirmed a Europe-wide outbreak of a multidrug-resistant Mycobacterium tuberculosis strain in 29 refugees from the Horn of Africa. The
An international tuberculosis consortium—including the Research Center Borstel—has succeeded in developing a standardised and internationally recognised method that is able to better predict in
German scientists from the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection Research (DZIF) in Braunschweig and Nigerian researchers are applying the new mobile
DZIF researchers from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) produced a molecule that provides a way to visualise Pseudomonas infection. The scientists published their
Initial associations with the term “emerging infections” usually involve diseases like Ebola and MERS or chikungunya and Zika fever. However, dangerous zoonoses, i.e. viral infections that can spread
In the light of growing antibiotic resistance, developing alternative tuberculosis treatment approaches is of critical importance. Scientists at the Research Center Borstel and the DZIF have now shown
The Usutu virus endangers birds and has been circulating in Germany since 2010. However, estimating its impact on bird populations in the outbreak region has hardly been possible up to now. For the
Scientists have elucidated the Zika burden in a Brazilian metropolis. Their data indicate: the outbreak may be coming to an end and further outbreaks in the region seem unlikely. The study has also
